Advertisement

Topics

Statement from Peter Marks, M.D., Ph.D., Director, FDA’s Center for Biologics Evaluation and Research

10:15 EDT 28 Jul 2016 | FDA

The FDA is tasked with taking important steps to respond to the emerging Zika virus outbreak. One of the agency’s key public health responsibilities is to help ensure the safety of the nation’s blood supply.

Original Article: Statement from Peter Marks, M.D., Ph.D., Director, FDA’s Center for Biologics Evaluation and Research

NEXT ARTICLE

More From BioPortfolio on "Statement from Peter Marks, M.D., Ph.D., Director, FDA’s Center for Biologics Evaluation and Research"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...